163. Combined MRI, high-resolution manometry and a randomised trial of bisacodyl versus hyoscine show the significance of an enlarged colon in constipation: the RECLAIM study.
作者: Victoria Wilkinson-Smith.;Mark Scott.;Alex Menys.;Lukasz Wiklendt.;Luca Marciani.;David Atkinson.;Stefano Sansone.;Ausra Zdanaviciene.;Carol Coupland.;Charles H Knowles.;Philip Dinning.;Stuart A Taylor.;Penny Gowland.;Caroline Louise Hoad.;Maura Corsetti.;Robin C Spiller.
来源: Gut. 2024年74卷1期35-44页
Colonic motility in constipation can be assessed non-invasively using MRI.
165. IQGAP3 signalling mediates intratumoral functional heterogeneity to enhance malignant growth.
作者: Mitsuhiro Shimura.;Junichi Matsuo.;ShuChin Pang.;Nawaphat Jangphattananont.;Aashiq Hussain.;Muhammad Bakhait Rahmat.;Jung-Won Lee.;Daisuke Douchi.;Jasmine Jie Lin Tong.;Khine Myint.;Supriya Srivastava.;Ming Teh.;Vivien Koh.;Wei Peng Yong.;Jimmy Bok Yan So.;Patrick Tan.;Khay-Guan Yeoh.;Michiaki Unno.;Linda Shyue Huey Chuang.;Yoshiaki Ito.
来源: Gut. 2025年74卷3期364-386页
The elevation of IQGAP3 expression in diverse cancers indicates a key role for IQGAP3 in carcinogenesis. Although IQGAP3 was established as a proliferating stomach stem cell factor and a regulator of the RAS-ERK pathway, how it drives cancer growth remains unclear.
166. QUAIDE - Quality assessment of AI preclinical studies in diagnostic endoscopy.
作者: Giulio Antonelli.;Diogo Libanio.;Albert Jeroen De Groof.;Fons van der Sommen.;Pietro Mascagni.;Pieter Sinonquel.;Mohamed Abdelrahim.;Omer Ahmad.;Tyler Berzin.;Pradeep Bhandari.;Michael Bretthauer.;Miguel Coimbra.;Evelien Dekker.;Alanna Ebigbo.;Tom Eelbode.;Leonardo Frazzoni.;Seth A Gross.;Ryu Ishihara.;Michal Filip Kaminski.;Helmut Messmann.;Yuichi Mori.;Nicolas Padoy.;Sravanthi Parasa.;Nastazja Dagny Pilonis.;Francesco Renna.;Alessandro Repici.;Cem Simsek.;Marco Spadaccini.;Raf Bisschops.;Jacques J G H M Bergman.;Cesare Hassan.;Mario Dinis Ribeiro.
来源: Gut. 2024年74卷1期153-161页
Artificial intelligence (AI) holds significant potential for enhancing quality of gastrointestinal (GI) endoscopy, but the adoption of AI in clinical practice is hampered by the lack of rigorous standardisation and development methodology ensuring generalisability. The aim of the Quality Assessment of pre-clinical AI studies in Diagnostic Endoscopy (QUAIDE) Explanation and Checklist was to develop recommendations for standardised design and reporting of preclinical AI studies in GI endoscopy.The recommendations were developed based on a formal consensus approach with an international multidisciplinary panel of 32 experts among endoscopists and computer scientists. The Delphi methodology was employed to achieve consensus on statements, with a predetermined threshold of 80% agreement. A maximum three rounds of voting were permitted.Consensus was reached on 18 key recommendations, covering 6 key domains: data acquisition and annotation (6 statements), outcome reporting (3 statements), experimental setup and algorithm architecture (4 statements) and result presentation and interpretation (5 statements). QUAIDE provides recommendations on how to properly design (1. Methods, statements 1-14), present results (2. Results, statements 15-16) and integrate and interpret the obtained results (3. Discussion, statements 17-18).The QUAIDE framework offers practical guidance for authors, readers, editors and reviewers involved in AI preclinical studies in GI endoscopy, aiming at improving design and reporting, thereby promoting research standardisation and accelerating the translation of AI innovations into clinical practice.
167. Novel mouse model for studying transmural intestinal fibrosis and creeping fat formation in stricturing Crohn's disease.
作者: Xiaofen Lv.;Yunqing Zeng.;Wenlong Ma.;Yuan Zheng.;Tengkai Wang.;Mingru Liu.;Di Zhang.;Lixiang Li.;Xiuli Zuo.;Yanqing Li.;Jiaoyang Lu.
来源: Gut. 2025年74卷4期686-689页 168. Endoscopic sphincterotomy to prevent post-ERCP pancreatitis after self-expandable metal stent placement for distal malignant biliary obstruction (SPHINX): a multicentre, randomised controlled trial.
作者: Anke M Onnekink.;Myrte Gorris.;Noor Lh Bekkali.;Philip Bos.;Paul Didden.;J Enrique Dominguez-Muñoz.;Pieter Friederich.;Emo E van Halsema.;Wouter L Hazen.;Nadine C van Huijgevoort.;Akin Inderson.;Maarten Ajm Jacobs.;Jan J Koornstra.;Sjoerd Kuiken.;Bob Ch Scheffer.;Hilbert Sloterdijk.;Ellert J van Soest.;Niels G Venneman.;Rogier P Voermans.;Thomas R de Wijkerslooth.;Janneke Wonders.;Roeland Zoutendijk.;Serge Jlb Zweers.;Paul Fockens.;Robert C Verdonk.;Roy L J van Wanrooij.;Jeanin E Van Hooft.; .
来源: Gut. 2025年74卷2期246-254页
Endoscopic retrograde cholangiopancreatography (ERCP) with fully covered self-expandable metal stent (FCSEMS) placement is the preferred approach for biliary drainage in patients with suspected distal malignant biliary obstruction (MBO). However, FCSEMS placement is associated with a high risk of post-ERCP pancreatitis (PEP). Endoscopic sphincterotomy prior to FCSEMS placement may reduce PEP risk.
169. Effects of tenofovir disoproxil fumarate on intrahepatic viral burden and liver immune microenvironment in patients with chronic hepatitis B.
作者: David Z Pan.;Cameron M Soulette.;Abhishek Aggarwal.;Dong Han.;Nicholas van Buuren.;Peiwen Wu.;Becket Feierbach.;Jaw-Town Lin.;Cheng-Hao Tseng.;Chi-Yi Chen.;Bryan Downie.;Hongmei Mo.;Lauri Diehl.;Li Li.;Simon P Fletcher.;Scott Balsitis.;Ricardo Ramirez.;Vithika Suri.;Yao-Chun Hsu.
来源: Gut. 2025年74卷4期628-638页
The impact of nucleos(t)ide analogues on intrahepatic viral burden and immune microenvironment in patients with chronic hepatitis B (CHB) is not clear.
171. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates.
作者: Karol M Córdoba.;Daniel Jericó.;Lei Jiang.;María Collantes.;Manuel Alegre.;Leyre García-Ruiz.;Oscar Manzanilla.;Ana Sampedro.;Jose M Herranz.;Iñigo Insausti.;Antonio Martinez de la Cuesta.;Francesco Urigo.;Patricia Alcaide.;María Morán.;Miguel A Martín.;José Luis Lanciego.;Thibaud Lefebvre.;Laurent Gouya.;Gemma Quincoces.;Carmen Unzu.;Sandra Hervas-Stubbs.;Juan M Falcón-Pérez.;Estíbaliz Alegre.;Azucena Aldaz.;María A Fernández-Seara.;Iván Peñuelas.;Pedro Berraondo.;Paolo G V Martini.;Matias A Avila.;Antonio Fontanellas.
来源: Gut. 2025年74卷2期270-283页
Acute intermittent porphyria (AIP) is a rare metabolic disorder caused by haploinsufficiency of hepatic porphobilinogen deaminase (PBGD), the third enzyme of the heme biosynthesis. Individuals with AIP experience neurovisceral attacks closely associated with hepatic overproduction of potentially neurotoxic heme precursors.
174. Unravelling lipidomic disruptions across multiple tissues in Chd8-mutant ASD mice through integration of lipidomics and single-cell transcriptomics.
作者: You Yu.;Bing Zhang.;Ning Wang.;Zhenqiang Zuo.;Peifeng Ji.;Fangqing Zhao.
来源: Gut. 2025年74卷4期684-686页 175. Multiomics of the intestine-liver-adipose axis in multiple studies unveils a consistent link of the gut microbiota and the antiviral response with systemic glucose metabolism.
作者: Anna Castells-Nobau.;José Maria Moreno-Navarrete.;Lisset de la Vega-Correa.;Irene Puig.;Massimo Federici.;Jiuwen Sun.;Remy Burcelin.;Laurence Guzylack-Piriou.;Pierre Gourdy.;Laurent Cazals.;María Arnoriaga-Rodríguez.;Gema Frühbeck.;Luisa Maria Seoane.;José López-Miranda.;Francisco J Tinahones.;Carlos Dieguez.;Marc-Emmanuel Dumas.;Vicente Pérez-Brocal.;Andrés Moya.;Nikolaos Perakakis.;Geltrude Mingrone.;Stefan Bornstein.;Jose Ignacio Rodriguez Hermosa.;Ernesto Castro.;Jose Manuel Fernández-Real.;Jordi Mayneris-Perxachs.
来源: Gut. 2025年74卷2期229-245页
The microbiota is emerging as a key factor in the predisposition to insulin resistance and obesity.
177. p53 mutation biases squamocolumnar junction progenitor cells towards dysplasia rather than metaplasia in Barrett's oesophagus.
作者: Guodong Lian.;Ermanno Malagola.;Chengguo Wei.;Qiongyu Shi.;Junfei Zhao.;Masahiro Hata.;Hiroki Kobayashi.;Yosuke Ochiai.;Biyun Zheng.;Xiaofei Zhi.;Feijing Wu.;Ruhong Tu.;Osmel Companioni Nápoles.;Wenjing Su.;Leping Li.;Changqing Jing.;Man Chen.;Leah Zamechek.;Richard Friedman.;Karol Nowicki-Osuch.;Michael Quante.;Jianwen Que.;Timothy C Wang.
来源: Gut. 2025年74卷2期182-196页
While p53 mutations occur early in Barrett's oesophagus (BE) progression to oesophageal adenocarcinoma (EAC), their role in gastric cardia stem cells remains unclear.
178. Establishment of enterically transmitted hepatitis virus animal models using lipid nanoparticle-based full-length viral genome RNA delivery system.
作者: Tianxu Liu.;Jian Li.;Xin Yin.;Fengmin Lu.;Hui Zhao.;Lin Wang.;Cheng-Feng Qin.
来源: Gut. 2025年74卷3期467-476页
Enterically transmitted hepatitis viruses, such as hepatitis A virus (HAV) and hepatitis E virus (HEV), remain notable threats to public health. However, stable and reliable animal models of HAV and HEV infection are lacking.
179. Nuclear translocation of plasma membrane protein ADCY7 potentiates T cell-mediated antitumour immunity in HCC.
作者: Jianan Chen.;Youhai Jiang.;Minghui Hou.;Chunliang Liu.;Erdong Liu.;Yali Zong.;Xiang Wang.;Zhengyuan Meng.;Mingye Gu.;Yu Su.;Hongyang Wang.;Jing Fu.
来源: Gut. 2024年74卷1期128-140页
The potency of T cell-mediated responses is a determinant of immunotherapy effectiveness in treating malignancies; however, the clinical efficacy of T-cell therapies has been limited in hepatocellular carcinoma (HCC) owing to the extensive immunosuppressive microenvironment.
180. Impact of margin thermal ablation after endoscopic mucosal resection of large (≥20 mm) non-pedunculated colonic polyps on long-term recurrence.
作者: Timothy O'Sullivan.;Francesco Vito Mandarino.;Julia L Gauci.;Anthony M Whitfield.;Clarence Kerrison.;James Elhindi.;Catarina Neto do Nascimento.;Sunil Gupta.;Oliver Cronin.;Anthony Sakiris.;Juan Francisco Prieto Aparicio.;Sophie Arndtz.;Gregor Brown.;Spiro Raftopoulos.;David Tate.;Eric Y Lee.;Stephen J Williams.;Nicholas Burgess.;Michael J Bourke.
来源: Gut. 2024年74卷1期67-74页
The efficacy of colorectal endoscopic mucosal resection (EMR) is limited by recurrence and the necessity for conservative surveillance. Margin thermal ablation (MTA) after EMR has reduced the incidence of recurrence at the first surveillance colonoscopy at 6 months (SC1). Whether this effect is durable to second surveillance colonoscopy (SC2) is unknown. We evaluated long-term surveillance outcomes in a cohort of LNPCPs that have undergone MTA.
|